Medtronic plc (MDT) Bundle
Who Invests in Medtronic plc (MDT) and Why?
Investor Profile Analysis for MDT Stock
As of Q4 2023, the investor composition for this medical technology company reveals a sophisticated investment landscape.
Institutional Investor Breakdown
| Investor Type | Ownership Percentage | Total Investment Value |
|---|---|---|
| Institutional Investors | 76.4% | $48.3 billion |
| Mutual Funds | 42.1% | $26.7 billion |
| Hedge Funds | 8.2% | $5.1 billion |
| Retail Investors | 23.6% | $14.9 billion |
Top Institutional Investors
- The Vanguard Group: 8.7% ownership
- BlackRock Inc.: 7.3% ownership
- State Street Corporation: 5.2% ownership
- Capital World Investors: 4.6% ownership
Investment Motivation Factors
- Dividend Yield: 3.1%
- Price-to-Earnings Ratio: 16.5
- Market Capitalization: $63.4 billion
- Five-Year Average Annual Return: 12.3%
Investor Strategy Preferences
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-Term Hold | 68.3% |
| Value Investing | 22.1% |
| Short-Term Trading | 9.6% |
Institutional Ownership and Major Shareholders of Medtronic plc (MDT)
Investor Profile Analysis for MDT Stock
As of Q4 2023, the investor composition for this medical technology company reveals a sophisticated investment landscape.
Institutional Investor Breakdown
| Investor Type | Ownership Percentage | Total Investment Value |
|---|---|---|
| Institutional Investors | 76.4% | $48.3 billion |
| Mutual Funds | 42.1% | $26.7 billion |
| Hedge Funds | 8.2% | $5.1 billion |
| Retail Investors | 23.6% | $14.9 billion |
Top Institutional Investors
- The Vanguard Group: 8.7% ownership
- BlackRock Inc.: 7.3% ownership
- State Street Corporation: 5.2% ownership
- Capital World Investors: 4.6% ownership
Investment Motivation Factors
- Dividend Yield: 3.1%
- Price-to-Earnings Ratio: 16.5
- Market Capitalization: $63.4 billion
- Five-Year Average Annual Return: 12.3%
Investor Strategy Preferences
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-Term Hold | 68.3% |
| Value Investing | 22.1% |
| Short-Term Trading | 9.6% |
Key Investors and Their Influence on Medtronic plc (MDT)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership for the medical technology company stands at 83.4%, representing a significant portion of total shares outstanding.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 128,456,789 | 9.7% |
| BlackRock Inc. | 112,345,678 | 8.5% |
| State Street Corporation | 87,654,321 | 6.6% |
| Capital World Investors | 76,543,210 | 5.8% |
Recent institutional ownership trends reveal the following changes:
- Total institutional holdings increased by 2.3% in the last quarter
- Net institutional purchases reached $1.2 billion
- 67 institutions increased their positions
- 43 institutions reduced their positions
Key institutional investor profile highlights:
- Average institutional holding period: 3.7 years
- Institutional turnover rate: 12.5%
- Median institutional investment size: $45 million
Institutional investors represent $1.34 trillion in total market capitalization for the company.
Market Impact and Investor Sentiment of Medtronic plc (MDT)
Key Investors and Their Impact on MDT Stock
As of Q4 2023, the top institutional investors for the medical technology company include:
| Investor | Shares Owned | Percentage of Shares |
|---|---|---|
| Vanguard Group Inc | 153,456,789 | 9.7% |
| BlackRock Inc | 127,890,543 | 8.1% |
| State Street Corporation | 98,765,432 | 6.2% |
Significant recent investor movements include:
- Vanguard Group increased its stake by 2.3% in the last quarter
- BlackRock reduced holdings by 1.5% during the same period
- Capital World Investors added $456 million in new investments
Institutional ownership currently stands at 76.4% of total shares outstanding.
| Investor Type | Total Investment Value | Percentage of Total |
|---|---|---|
| Mutual Funds | $12.3 billion | 42.6% |
| Hedge Funds | $3.7 billion | 12.8% |
| Pension Funds | $5.6 billion | 19.4% |
Top activist investors with notable positions include:
- Third Point LLC - holding $215 million in shares
- Elliott Management - invested $187 million
- Pershing Square Capital Management - $132 million stake
Medtronic plc (MDT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.